A disease-treatment ontology is being developed to model and represent treatment information found in medical abstracts. Treatment information extracted from medical abstracts and medical articles can then be encoded in this ontology and used for information retrieval, question-answering, summarisation and knowledge discovery. This paper explains the initial version of the ontology developed based on an analysis of 50 medical abstracts on colon cancer therapy retrieved from the Medline database. The ontology divides disease-treatment information into five classes-disease, treatment, condition, effect, and evidence. The sub-classes, properties and instances of these main classes are discussed with examples.
INTRODUCTION
A disease-treatment ontology is being developed to model and represent treatment information found in the abstracts of medical articles. This is part of a bigger project to develop an automatic extraction system to extract treatment information from medical abstracts retrieved from the Medline database, to support information retrieval, question-answering, summarisation, and knowledge discovery. The purpose of the ontology is to serve as a knowledge base to store the extracted information and support these functions.
The ontology is also expected to be useful in supporting synthesis of information extracted from different publications, and inferencing of potentially new relations between chemical substances and effects on diseases, such as envisaged by Swanson 1,2 and others. Information stored in an ontology can also support evidence-based medicine 3, 4 -to alert doctors to the range and quality of clinical data available to make informed treatment decisions. A disease-treatment ontology is potentially important for use in medical digital libraries/portals and medical information systems.
The disease-treatment ontology is being constructed as an enhancement to existing medical taxonomies and ontologies. We adopted the Unified Medical Language System (UMLS) semantic network 5, 6 , the Medical Subject Headings (MeSH) 7 , and the NCI (National Cancer Institute) thesaurus (http://bioportal.bioontology.org/ ontologies/39478 & http://ncit.nci.nih.gov/ncitbrowser) as the base medical ontology and enriched with relations to link potential medical treatments with diseases. The following URI was assigned to the disease-treatment ontology: http://dis.sci.ntu.edu.sg/medical/disease-treat ment.v1#. The initial disease-treatment ontology was developed based on analyses of 40 medical abstracts on colon cancer therapy, and evaluation of additional 10 abstracts. Many definitions of ontologies have been proposed in the literature from different perspectives. Perhaps the most often quoted definition is by Gruber 8 : "A body of formally represented knowledge is based on a conceptualisation: the objects, concepts, and other entities that are assumed to exist in some area of interest and the relationships that hold among them 9 . A conceptualisation is an abstract, simplified view of the world that we wish to represent for some purpose. An ontology is an explicit specification of a conceptualisation." In practice, an ontology is a set of concepts or classes, represented by terms, linked with semantic relations or properties. The most common semantic relation is the isa or subclass-of relation that organises the concepts into taxonomies with a hierarchical structure. Additional semantic relations enhance the ontology by specifying relations between concepts in different taxonomies. More complex rules, called axioms, specify constraints and relationships among two or more concepts. The XML-based representation formalism for ontologies adopted by the World Wide Web Consortium is the Web Ontology Language 10 . OWL offers three sub-languages of increasing expressiveness: OWL Lite, OWL DL (Description Logics) and OWL Full. In this study, we adopted OWL DL as the knowledge representation formalism and encoding scheme for the ontology. OWL DL is said to provide "maximum expressiveness while retainig computational completeness and decidability" 10 . An ontology represented in OWL can be divided into two parts: (i) the set of classes and properties (i.e. semantic relations), and (ii) the set of instances (objects) of the classes and instances of properties. This paper describes the set of classes and properties in the ontology. The instances would be constructed from the information extracted from the medical abstracts. However, some of the classes are expected to be "closed classes" with a limited number of instances. We are attempting to construct a comprehensive list of instances for these closed classes.
CURRENT MEDICAL ONTOLOGIES
The majority of the literature on biomedical ontology development and use is focused on gene ontologies, particularly the Gene Ontology Project 11, 12 , to annotate genes, sequences, and gene expressions and functions. Ontologies on other biomedical domains have been developed for the following purposes:
For modelling biological systems. For example, Antezana, et al. 13 developed a cell-cycle ontology to represent the cell cycle process and to support analysis of cell cycle-related molecular network components. Similarly, Matos 14 developed. The foundational model of anatomy ontology-a spatial-structural ontology of the entities and relations, which represent the structure of the human body at different levels of granularity.
A search of the literature did not locate any generalpurpose disease-treatment ontology, especially one that can represent information found in published medical papers. However, some treatment-related semantic relations are defined in the UMLS semantic network 25 There are also relations linking type of surgery or procedure with types of cancer growths:
Procedure_Has_Excised_Anatomy

Procedure_Has_Completely_Excised_Anatomy
Procedure_Has_Partially_Excised_Anatomy Procedure_May_Have_Excised_Anatomy
Some of the relations incorporate modality indicators (e.g. "may have" and "partially"). However, the NCI and UMLS relations are binary valued and relate a treatment to a disease, but cannot model related details of the treatment, disease, effect and research evidence. Our focus is to develop an ontological structure that will link related aspects of treatment and disease together. Since the completion of this study, we have come across the PhD thesis of Williams 26 which reported the development of a breast cancer ontology based on a set of medical papers dealing with the treatment of invasive breast cancer with Tamoxifen. Willims' ontology focused on the chracteristics of the disease and patient, and the changes in various types of risks from the treatment. The treatment regimes themselves were not modelled in detail.
ONTOLOGY DEVELOPMENT METHODOLOGIES
Our disease-treatment ontology builds on existing medical taxonomies and ontologies-the UMLS semantic network, the Medical Subject Headings (MeSH) and the NCI Thesaurus. The additional concepts and semantic relations specified in the ontology will enrich the existing medical ontologies by linking diseases with potential medical treatments and representing additional details related to the treatment administration and dosage, the types of effects and the supporting research evidence. Several methodologies have been proposed in the literature for developing ontologies 27 , such as the Cyc method 28 Methontology 29 and the On-To-Knowledge method 30 . However, most of these were designed for solving particular difficulties in developing large-scale ontologies, such as managing geographically distant cooperative teams, easing enormous knowledge acquisition, and merging/alignment of heterogeneous ontologies 27 . These methods were not adopted for developing our disease-treatment ontology, which is a small-scale ontology. Ontology design remains partly an art, regardless of the method used 31 .
The ontology was developed based on the saturation principle 32 . The basic idea is that a training set of documents is used to build the ontology. Then a test set is used to evaluate whether the ontology covers most of the relevant concepts and relations in the domain. If new concepts are found in the test set, the test set documents is added to the training set and the new classes and properties are added to the ontology. A second test set is used to assess the ontology again, and the process iterated until no new concepts are found.
For the current disease-treatment ontology, 40 abstracts were used as the training set, where important concepts related to treatment were identified by manual analysis. The specific concepts were then generalised to derive broad classes and relations, which were likely to be applicable across different medical domains. An additional 10 abstracts as the test set were analysed in a similar way to identify new treatment-related concepts and relations not covered by the ontology. No new concepts were found in the test set. However, additional "instances" of concepts (e.g. particular drugs or procedures) were found. Therefore, the 40 abstracts were considered sufficient for developing a high-level diseasetreatment ontology for colon cancer. As an extension of the current study, sample abstracts from the breast cancer and heart disease domains are being analysed to find out if the current ontology is sufficient.
The ontology development process was carried out by the authors. Twenty-five abstracts were first analysed jointly by all the authors, with the last 15 abstracts analysed by one of the authors. All the classes and properties were reviewed by the authors to ensure logical consistency. Evaluation using the test set of 10 abstracts was carried out by two of the authors. Admittedly, there is some amount of subjectivity involved in developing an ontology, and some design decisions were made. Identification of challenges in developing such an ontology and the design decisions that had to be made are reported later.
The focus of the effort is to ensure that the ontology covers most of the treatment concepts and relations found in the abstracts, and is logical and principled (i.e. follows certain design principles decided by the team).
TOP-LEVEL OF DISEASE-TREATMENT ONTOLOGY
The top-level of the disease-treatment ontology is shown in Fig. 1 . Each square or node represents a class or concept. Each directed arc or arrow represents a property or relation. The top-class in the ontology is Disease-Treatment which represents specific treatments that are considered for a particular disease, as described in medical articles. An instance of a Disease-Treatment is not a specific treatment customised for a particular patient's condition, but a generic treatment that is applicable to a group of patients with a similar disease instance and condition. Condition refers to additional conditions or attributes of the patient that may affect the efficacy of the treatment. This includes the age and gender of the patient, medical history, and other diseases the patient has. Evidence refers to the research design and data reported in the medical article that supports the Effect.
In the OWL language, properties (i.e. relations) can have sub-properties (sub-relations) to form a relation hierarchy. We define two sub-properties for the hasTreatment property to handle more complex treatments:
Currently no constraints are imposed on the number of times each component can occur for a DiseaseTreatment. So a treatment may comprise a combination of treatments (e.g. two drugs, or a drug and surgery) and may be applied to a combination of diseases in a patient, with multiple effects. There may also be multiple studies (evidence) for this disease-treatment.
We now take a closer look at each of the top-level classes of Disease-Treatment.
THE DISEASE CLASS
The Disease class is specified as equivalentClass to the Diseases class in MeSH. An instance of Disease will be an instance of one of the sub-classes of MeSH Diseases. Alternatively, we can import the Disease, Disorder or Finding taxonomy from the NCI Thesaurus.
Instances of a Disease would have several properties, depending on the type of disease. The list of properties of the Disease class is given in Fig. 2 . We have specified some general properties that are applicable to many types of diseases:
hasLocation->Anatomy-equivalent to the Anatomy class in MeSH and the Anatomic Structure, System or Substance class in the NCI Thesaurus
hasPhysicalFeature->Feature hasDuration->TemporalQuantity hasDiseaseModifier-> DiseaseModifier
The property hasPhysicalFeatures that can be subdivided into sub-properties to represent various types of physical features, including hasSize-> Quantity. A list of common physical features encountered in medical abstracts is being constructed. It is expected that each disease domain will have its own peculiar set of physical (25) , sprawling (19) or spreading flat (7) in rectum (24) , sigmoid (18) or colon (9) . Polyp diameter ranged 1.0-1.9 cm (12 adenomas), 2-2.9 (18) or 3-5 cm (21) ."
The Quantity class is used for all kinds of measures, and have the properties quantityValue and quantityUnit, e.g. Specialised properties for specific types of diseases need to be developed. Figure 3 shows the properties defined for the Treatment class. The Treatment class has the sub- classes Therapeutics and SurgicalProcedures taken from MeSH or from NCI Thesaurus-"Chemotherapy Regimen or Agent Combination", "Drug, Food, Chemical or Biomedical Material", "Gene", and "Intervention or Procedure".
THE TREATMENT CLASS
The Treatment class is associated with a property that we call AdministrationScheme which is divided into two components (i.e. properties):
hasFrequency->AdministrationFrequency-indicating how often the treatment is administered, e.g. 3 times a day, every 4 hours, exactly once, or whenever needed).
hasDuration->AdministrationDuration-indicating how many times or for how long the treatment is administered, e.g. 10 days, or exactly once.
AdministrationScheme has two subclasses:
AdministrationCourse refers to one course of treatment AdministrationCycle refers to more complex treatments where a course of treatment has to be repeated for several cycles at regular intervals.
Thus AdministrationCourse refers to a local cycle whereas AdministrationCycle refers to a global or higherlevel cycle. For example, in the text "one of the adjuvant treatment schemes: 5-FU 450 mg/m2 and leucovorin 100 mg/m 2 x 5 days every 4 weeks; six cycles" indicates an AdministrationCourse once a day lasting 5 days, with an AdministrationCycle of one course every 4 weeks lasting 6 cycles. Additional properties are also specified for specific sub-classes of Treatment. Two sub-classes of cancer treatment are of particular interest: 
THE EFFECT CLASS
The properties of the Effect class are shown in Fig.  4 . The properties are:
hasMeasurementMethod->MeasurementMethod-the method used for measuring the effect.
hasModality->Modality-the degree of confidence or the truth value of the occurrence of the effect, i.e. "possible", "probable", "unlikely", "true", and "negation". hasEffectObject->Object-the object that is affected.
hasObjectAttribute->ObjectAttribute-the specific attribute of the object affected.
hasEffectType->EffectType-for example, "reduce", "inhibit", "prevent", and "remove".
hasEffectValue->EffectValue-the direction and extent of the effect. EffectValue has the properties value, comparisonValue differenceValue and percentDifference, which are linked to some Quantity.
atTime->TemporalObject-to indicate when or how long after treatment the effect occurs.
hasEvidence->Evidence to link to details of the research study and research results.
The Effect class is also divided into a taxonomy of sub-classes:
Effect
ComparisonEffect compares the effect of one treatment with that of another PatientEffect-the effect is expressed holistically from the perspective of the patient, e.g. mortality, 5-year survival rate, quality of life in the first postoperative month, mental health, and minimal follow-up period.
DiseaseEffect-specifies the effect on the disease, e.g. "the colon polyps were removed completely through polypectomies."
SideEffect-a secondary and usually adverse effect/ reaction/complication, e.g. "The majority of our complications were bacterial infections, followed by rejections and relaparotomies."
ComparisonEffect has two properties:
hasComparisonObject->Treatment-the treatment for the same disease being compared against) For example, in an article that compares laparoscopic surgery with open surgery for rectal cancer, the text "the mean operative time was significantly increased in the laparoscopic group; however, this group showed faster recovery of bowel function. Although anastomotic leakage was comparable between 2 groups, surgical wound infection was significantly higher in open surgery group" indicates evaluation criteria of "operative time", "recovery" rate, "anastomotic leakage" and "infection" during the comparison.
THE CONDITION CLASS
The Condition class has three sub-classes and one property (Fig. 6) :
PatientCondition refers to information on age, gender and other personal attributes, and the patient's medical history. Personal attributes is equivalent to the Personal Attributes class in the NCI thesaurus.
DiseaseCondition specifies other co-existing diseases, e.g. "accompanied with colon ileus" and "the neighbouring organs are affected." Table 1 lists the EffectType we have encountered in the 50 medical abstracts analysed. Figure 5 gives an example text illustrating some of the elements of Effect.
The class TemporalObject has two sub classes:
RelativeTime refers to time relative to a ReferenceEvent.
AbsoluteTime refers to an absolute time point or a range of time.
For example, the text "the patient died 1 year after the first medical examination" indicates that death (PatientEffect, explained later) occurred at a RelativeTime.value of 1 year after the first medical examination (ReferenceEvent). TreatmentCondition indicates the supportive/ optional/recommended medical environment prior to or during the treatment, including treatment history, e.g. "treatment applied after resection surgery" and "in combination with surgery and chemotherapy."
hasModality->Modality refers to modal modifiers such as negation and possibility.
For instance, the text "laparoscopic approach is only contraindicated if the neighbouring organs are affected" could be represented as an instance of DiseaseCondition, i.e. "the neighbouring organs are affected" with Modality "negation". The following text serves as an example for three kinds of conditions: "A 50-year-old man was diagnosed with non-resectable scirrhous gastric cancer of antrum accompanied with colon ileus due to direct invasion of the transverse colon. As the ileus improved after cecostomy, chemotherapy with TS-1/ cisplatin(CDDP) was first performed. Because of no response, 4 cycles of paclitaxel (PTX)/doxifluridine (5'-DFUR) therapy was performed as second-line chemotherapy." The following conditions are specified:
PatientCondition: Age "50 years", gender "male" DiseaseCondition: Co-existing disease "colon ileus" TreatmentCondition: TreatmentHistory "cecostomy" and "chemotherapy with TS-1/cisplatin(CDDP)".
THE EVIDENCE CLASS
The Evidence class has the following properties ( Fig. 7): providedBy->Organisation hasResearchLocation->Location hasResearchType->ResearchType e.g. systematic review, randomised controlled trial, cohort studies, case control studies, case reports/series, animal research/laboratory studies. 
CONCLUSION
We have described the initial version of the diseasetreatment ontology that we are developing to encode treatment information reported in medical abstracts in the Medline database. The ontology was developed from an analysis of 40 abstract in the domain of colon cancer therapy. A further 10 abstracts were used to verify that the ontology is reasonably complete and can represent most of the information related to colon cancer therapy. We found that the ontology can cover all the types of information (classes) associated with colon cancer therapy in the 10 test abstracts. An example of a diseasetreatment instance extracted from a medical abstract and represented using the ontology is given in the Appendix 1. The ontology instance is presented in a template format, rather than in OWL, for readability. Current work is focused on constructing a comprehensive list of the subclasses of the main classes and instances of the closed classes. Closed classes are classes that have a limited number of instances that can be enumerated completely, e.g. Modality and EffectType.
The ontology is being extended to cover treatment of two other domains-breast cancer and heart disease. It was found that these two domains have different kinds of treatments and the following additional treatment concepts need to be added to the ontology: Radiation Therapy (a subclass of cancer treatment and equivalent to the Radiation Therapy class in the NCI Thesaurus), Notes:
1. Two types of colon lesions are mentioned in the abstract. Each lesion would be represented as a separate diseasetreatment instance. However, they are placed together in this example for easy reading. 
